ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

1.0301
-0.0099
(-0.95%)
At close: July 09 4:00PM
0.90
-0.1301
( -12.63% )
After Hours: 5:33PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.90
Bid
0.95
Ask
1.15
Volume
10,391
1.03 Day's Range 1.0962
0.90 52 Week Range 11.07
Market Cap
Previous Close
1.04
Open
1.05
Last Trade
43
@
0.92
Last Trade Time
Financial Volume
$ 11,133
VWAP
1.0714
Average Volume (3m)
35,344
Shares Outstanding
5,473,126
Dividend Yield
-
PE Ratio
-0.12
Earnings Per Share (EPS)
-8.94
Revenue
-
Net Profit
-48.93M

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was $1.04. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of $ 0.90 to $ 11.07.

Hepion Pharmaceuticals currently has 5,473,126 shares outstanding. The market capitalization of Hepion Pharmaceuticals is $5.69 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.12.

HEPA Latest News

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b โ€˜ASCEND-NASHโ€™ Trial

EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

EDISON, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial intelligence assisted therapeutic...

Hepion Pharmaceuticals to Present at NASH-TAG 2024

EDISON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (โ€œAIโ€)-driven...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-18.18181818181.11.10.96104551.02290162CS
4-0.18-16.66666666671.081.220.9209501.06525293CS
12-1.34-59.82142857142.242.240.9353441.33367106CS
26-2.21-71.06109324763.113.48990.9559752.00372617CS
52-8.95-90.86294416249.8511.070.9515313.13169893CS
156-38.9-97.738693467339.840.920.939759822.63734455CS
260-61.3-98.553054662462.21670.998449245.69126046CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.1M
ZAPPZapp Electric Vehicles Group Ltd
$ 17.9001
(93.72%)
45.47M
PEGYPineapple Energy Inc
$ 2.30
(91.67%)
77.43M
ATNF180 Life Sciences Corporation
$ 2.9017
(79.12%)
31.2M
QUREuniQure NV
$ 6.65
(75.93%)
51.49M
NVOSNovo Integrated Sciences Inc
$ 0.4874
(-35.44%)
3.11M
FAASDigiAsia Corporation
$ 3.65
(-34.17%)
48.97k
INDVIndivior PLC
$ 10.18
(-33.64%)
2.95M
CLEUChina Liberal Education Holdings Ltd
$ 0.3905
(-31.59%)
9.22M
HELEHelen of Troy Ltd
$ 64.30
(-27.76%)
5.47M
NVDANVIDIA Corporation
$ 131.38
(2.48%)
286.78M
MAXNMaxeon Solar Technologies Ltd
$ 0.2451
(-9.22%)
232.72M
TSLATesla Inc
$ 262.33
(3.71%)
160.63M
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.1M
INTCIntel Corporation
$ 34.59
(1.77%)
97.76M

HEPA Discussion

View Posts
Monksdream Monksdream 3 days ago
HEPA under $2
๐Ÿ‘๏ธ0
Awl416 Awl416 3 months ago
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b โ€˜ASCEND-NASHโ€™ Trial
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
HEPA new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
HEPA new 52 week low
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 12 months ago
POS
๐Ÿ‘๏ธ0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 year ago
Any thoughts on whether they could see accelerated approval now? results were good and there are no good alternatives.
๐Ÿ‘๏ธ0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 year ago
What if it is a lush partnership instead?
๐Ÿ‘๏ธ0
shurtha2000 shurtha2000 1 year ago
Thanks
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
Absolutely correct, sir
๐Ÿ‘๏ธ0
make it happen make it happen 1 year ago
Don't forget it's a delinquent stock has failed to meet requirements ie r/s to raise more funds rinse and repeat for at least another 3 years and if one bad thing happens expect a 90% haircut immediately imho
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
people DUMPING knowing the OFFERING is imminentโ€ฆ
๐Ÿ‘๏ธ0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 year ago
GOOD CALL: after R/S This could be a moon shot on good top line results
๐Ÿ‘๏ธ0
da_stock_analyst da_stock_analyst 1 year ago
#HEPA ?? 117% move today! Looking strong and ready for tomorrow! $HEPA
๐Ÿ‘๏ธ0
make it happen make it happen 1 year ago
R/S, huge double digit negative returns, burning capital, zero Profitability

Management Effectiveness
Return on Assets -42.63%
Return on Equity  -78.41%

Cash Flow Statement
Operating Cash Flow -33.05M
Levered Free Cash Flow -16.86M

Profitability
Profit Margin. 0.00%
Operating Margin 0.00%

Yahoo

It is losing/spending more than its market cap. Imho will fade back to singles and dilute. It can't keep operations running without selling shares to share holders.
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
Yes (for up to $350 million)

and Yes (check the latest 10Q - very little cash left on hand)
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 1 year ago
DO THEY HAVE A SHELF OFFERING TO DRAW FROM?

ARE THEY CURRENTLY IN NEED OF CASH FROM AN OFFERING?

Message in reply to:
Offering tonight or tomorrow. Called it
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 1 year ago
GOOD CALL
after R/S This could be a moon shot on good top line results
👍️ 1
Pt3 Pt3 1 year ago
Call wrong baby ....Biden say No more offering.... inflation is extremely now
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
Offering tonight or tomorrow. Called it
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Might jus do it
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Gotta bust thru 16.40 and hold it
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$HEPA : Meeting those PRIMARY ENDPOINTS


Another MDGL kinda booster about to happen here.... now $15



GO $HEPA
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
This is not even .80c PS. Whose selling?
๐Ÿ‘๏ธ0
shurtha2000 shurtha2000 1 year ago
$15.73 building a new base
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
DUMPED all my 7zzzz at 16
๐Ÿ‘๏ธ0
shurtha2000 shurtha2000 1 year ago
Achieves primary and secondary endpoints its all good

https://finance.yahoo.com/news/hepion-pharmaceuticals-phase-2-altitude-110000500.html
๐Ÿ‘๏ธ0
shurtha2000 shurtha2000 1 year ago
Will Pre-market trading be suspended ?
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
830 am
Mondayโ€™s conference call update
๐Ÿ‘๏ธ0
shurtha2000 shurtha2000 1 year ago
after R/S This could be a moon shot on good top line results
👍️ 1
Ruffieruff Ruffieruff 1 year ago
But it all. Taking knife. We are scammed.
👍️ 1
makinezmoney makinezmoney 1 year ago
$HEPA: So the RS happened........ now $9

But on a downdip........... will have to get some more if this dips sub $9


GO $HEPA
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Your shares look like crap like the rest of us!! Pumper
👍️ 1
Ruffieruff Ruffieruff 1 year ago
Scumbags!!
👍️ 1
blue finch blue finch 1 year ago
I'd consider getting back at .36
๐Ÿ‘๏ธ0
blue finch blue finch 1 year ago
Why
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Good thing you dumped this dog.
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Pumper come back. Where have you been? We need another boost and lecture. Pumper rah rah rah.
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
This is dogchit!!
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Just added some SAB members. Lets see if we finally get some real info.
๐Ÿ‘๏ธ0
blue finch blue finch 1 year ago
Maybe they need a new CEO
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
End of day no volume dump. Manipulation
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
How your.80โ€™s doing. All you do is jump on momo plays and then disappear into the wind. HEPA doing itโ€™s thing alright. Going down.
👍️ 1
CreampieMafia CreampieMafia 1 year ago
He never made it back from hawaii LOL
๐Ÿ‘๏ธ0
blue finch blue finch 1 year ago
Big O/S here

Your thoughts on that little issue
Not very far along in the process and a very big O/S ?
๐Ÿ‘๏ธ0
Bertsllc Bertsllc 1 year ago
Hepion Pharmaceuticals to Participate in ACS-JPS Webinar on AI Drug Development

EDISON, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (โ€œAIโ€)-driven therapeutic drug development for the treatment of fibrotic diseases, including non-alcoholic steatohepatitis (โ€œNASHโ€), hepatocellular carcinoma (โ€œHCCโ€), and other chronic diseases, announces that its Chief Executive Officer, Robert Foster, PharmD, PhD, and its Senior Vice President for Clinical Pharmacology and Analytics, Patrick Mayo, PhD, will be presenting during a webinar entitled โ€œHow Artificial Intelligence is Changing Drug Discoveryโ€ on Thursday, March 23rd at 1:00 p.m. Eastern Time.
https://finance.yahoo.com/news/hepion-pharmaceuticals-participate-acs-jps-201000894.html
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Where you been. We could use you around here.
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
If possible can you post the news out this afternoon. Thx
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Nothing but a 40k share dump a few moments ago. Also fun to be a shareholder here.
๐Ÿ‘๏ธ0
blue finch blue finch 1 year ago
Any word on the reverse split ?
๐Ÿ‘๏ธ0
Ruffieruff Ruffieruff 1 year ago
Still adding? Itโ€™s been real quiet since youโ€™ve taken off elsewhere.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock